Member Sign In
Member Sign Out
Cell & Gene Therapy
Webinars & Video
Apply to Join
Cell & Gene Therapy
Unchained Labs launches new automation software
Unchained Labs has released its LEA 10 automation software, which aims to enable researchers to navigate workflow bottlenecks and scientific challenges.
Bacteria use 'belt and braces' defense system vs. bacteriophages
Researchers have shown how a plasmid in the bacterium
uses a "belt and braces" approach to defend itself against bacteriophages. The breakthrough, published on October 18 in
Nucleic Acids Research
, could lead to new DNA-targeting biotechnology tools.
Prime Medicine expands gene editing platform
Prime Medicine has added new capabilities to its Prime gene editing platform based on new research developments.
Gamida highlights poster presentations at SITC 2021
Cell therapy firm Gamida Cell is directing attention to two poster presentations at the annual meeting of the Society for Immunotherapy of Cancer (SITC) involving its nicotinamide-enabled cell expansion technology.
Cardiovascular cell, gene therapy leaders discuss nascent field
The emerging field of cardiovascular cell and gene therapies shows great promise to significantly improve clinical outcomes, but it still faces key challenges, according to an October 13 plenary session at the Cell & Gene Meeting on the Mesa.
CGTBO editor comments on trends from Cell & Gene Meeting on the Mesa
Blake Middleton, editor of
Cell & Gene Therapy Business Outlook (CGTBO)
, was joined by Bruce Carlson, senior vice president of publications at Science and Medicine Group, to review the latest developments in therapies from the 2021 Cell & Gene Meeting on Mesa.
Charles River to partner with ATEM Structural Discovery
Charles River Laboratories International has inked a partnership with ATEM Structural Discovery to provide its clients with ATEM's cryoelectron microscopy service.
DNA Script joins Genome Project-write's advisory board
DNA Script has joined the industrial advisory board of Genome Project-write, which has developed a computer-aided design tool for genome design.
Opportunities abound in cell and gene therapy for discerning investors
CARLSBAD, CA - There are more opportunities in the cell and gene therapy sector than ever before. But to profit from them, investors must be more discerning than in the past, according to a panel of investors at the Cell & Gene Meeting on the Mesa on October 14.
Precision Advance aims to improve patient access to cell and gene therapy
Improving patient access to cell and gene therapy treatments is the goal of Precision Advance, an initiative of Precision Medicine Group. Precision Advance provides a set of interconnected services and personnel designed to help bring new therapies to market.
Exclusive content for ScienceBoard.com members on trends and outcomes that are influencing the future of scientific research.
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Earn points for contributing to research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Tweets by @ScienceBoard